What is the definition of a defaulter of antitubercular therapy according to guidelines?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 25, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Definition of Antitubercular Drug Defaulter

A defaulter from antitubercular therapy is defined as a patient who interrupts treatment for 2 or more consecutive months.

Guideline-Based Definition

The standard definition used in tuberculosis treatment programs and clinical practice guidelines consistently defines a defaulter as:

  • A patient who interrupts antituberculosis treatment for ≥2 consecutive months 1, 2, 3
  • This definition applies to both new cases and retreatment cases 1
  • The interruption period is measured from the time the patient misses scheduled appointments and fails to continue prescribed therapy 3

Clinical Context and Timing

When Default Typically Occurs

  • Intensive phase: The majority of defaults occur during the intensive phase of treatment, with median duration of treatment prior to default being 81 days (approximately 2.7 months) 1
  • Early hospitalization period: 61% of patients default while still hospitalized during intensive phase 4
  • Transition period: 26% default just before starting the continuation phase 4
  • Continuation phase: Additional defaults occur during continuation phase, with rates of 10.9% in new cases and 16.5% in retreatment cases 2

Distinction from Treatment Failure

It is important to distinguish defaulters from treatment failures:

  • Treatment failure is defined as continuously or recurrently positive cultures after 4 months of appropriate chemotherapy 5
  • Defaulters voluntarily interrupt treatment, whereas treatment failures continue therapy but do not respond microbiologically 5

Risk Factors for Default

Understanding who is at risk helps identify potential defaulters:

  • Previous treatment history: Former defaulters have significantly higher risk (adjusted OR: 33.2) 6
  • Socioeconomic factors: Low income (<$2,000/month), unemployment, being a pensioner 6, 4
  • Social factors: Homelessness, alcoholism, living alone or with friends rather than family 4, 3
  • Healthcare system factors: Treatment by non-pulmonologist (adjusted OR: 14.6), public health facility-based treatment observation 6
  • Ethnic and cultural factors: Non-Chinese ethnicity in Singapore studies, lack of family support 3

Clinical Implications

Management of Defaulters

When patients default and later return:

  • For patients who received DOT: Retreatment using standard intensive phase regimen until susceptibility results are available 5
  • For patients without DOT or irregular treatment: Higher risk of acquired drug resistance; consider expanded empiric regimen with consultation from drug-resistant TB experts 5
  • Expanded regimen components: Standard intensive phase (INH, RIF, PZA, EMB) plus later-generation fluoroquinolone, injectable agent, and potentially additional second-line drugs 5

Prevention Strategies

  • Enhanced monitoring: Patients with absence of disease stigma, low income, previous default history, and those treated by non-specialists require careful monitoring 6
  • Retrieval efforts: Current retrieval efforts after treatment interruption are often inadequate, with home visits failing to contact patients 41% of the time 1, 3
  • Community-based treatment: May reduce default rates compared to facility-based observation 1

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.